| ■ 영문 제목 : Global HIV Therapeutics Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00128 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 104 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 HIV 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (뉴클레오사이드-유사체 역전사 효소 억제제 (NRTI), 비뉴클레오사이드 역전사 효소 억제제 (NNRTI), 진입 및 융합 억제제, 프로테아제 억제제 (PI), 인테라제 억제제, 공동수용체 길항제)와 용도별 시장규모 (병원, 클리닉, 연구실) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 HIV 치료제 시장 점유율 - 지역별 HIV 치료제 시장규모 - 주요지역의 종류별 시장규모 (뉴클레오사이드-유사체 역전사 효소 억제제 (NRTI), 비뉴클레오사이드 역전사 효소 억제제 (NNRTI), 진입 및 융합 억제제, 프로테아제 억제제 (PI), 인테라제 억제제, 공동수용체 길항제) - 주요지역의 용도별 시장규모 (병원, 클리닉, 연구실) - 미주의 HIV 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 HIV 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 HIV 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 HIV 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 HIV 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Boehringer Ingelheim International GmbH, Merck & Co., ViiV Healthcare, AbbVie, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, Gilead Sciences, Johnson & Johnson, Cipla Limited - 조사의 결과/결론 |
According to this latest study, the 2021 growth of HIV Therapeutics will have significant change from previous year. By the most conservative estimates of global HIV Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the HIV Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of HIV Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Clinics
Labs
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim International GmbH
Merck & Co.
ViiV Healthcare
AbbVie
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
Cipla Limited
1 Scope of the Report 2 Executive Summary 3 HIV Therapeutics Market Size by Players 4 HIV Therapeutics by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global HIV Therapeutics Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. HIV Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Table 3. Major Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Table 4. Major Players of Entry and Fusion Inhibitors Table 5. Major Players of Protease Inhibitors (PIs) Table 6. Major Players of Integrase Inhibitors Table 7. Major Players of Coreceptor Antagonists Table 8. HIV Therapeutics Market Size CAGR by Type (2020-2026) & ($ Millions) Table 9. Global HIV Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 10. Global HIV Therapeutics Market Size Market Share by Type (2016-2021) Table 11. HIV Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions) Table 12. Global HIV Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 13. Global HIV Therapeutics Market Size Market Share by Application (2016-2021) Table 14. Global HIV Therapeutics Revenue by Players (2019-2021E) & ($ Millions) Table 15. Global HIV Therapeutics Revenue Market Share by Players (2019-2021E) Table 16. HIV Therapeutics Key Players Head office and Products Offered Table 17. HIV Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 18. New Products and Potential Entrants Table 19. Mergers & Acquisitions, Expansion Table 20. Global HIV Therapeutics Market Size by Regions 2016-2021 & ($ Millions) Table 21. Global HIV Therapeutics Market Size Market Share by Regions 2016-2021 Table 22. Americas HIV Therapeutics Market Size by Country (2016-2021) & ($ Millions) Table 23. Americas HIV Therapeutics Market Size Market Share by Country (2016-2021) Table 24. Americas HIV Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 25. Americas HIV Therapeutics Market Size Market Share by Type (2016-2021) Table 26. Americas HIV Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 27. Americas HIV Therapeutics Market Size Market Share by Application (2016-2021) Table 28. APAC HIV Therapeutics Market Size by Region (2016-2021) & ($ Millions) Table 29. APAC HIV Therapeutics Market Size Market Share by Region (2016-2021) Table 30. APAC HIV Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 31. APAC HIV Therapeutics Market Size Market Share by Type (2016-2021) Table 32. APAC HIV Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 33. APAC HIV Therapeutics Market Size Market Share by Application (2016-2021) Table 34. Europe HIV Therapeutics Market Size by Country (2016-2021) & ($ Millions) Table 35. Europe HIV Therapeutics Market Size Market Share by Country (2016-2021) Table 36. Europe HIV Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 37. Europe HIV Therapeutics Market Size Market Share by Type (2016-2021) Table 38. Europe HIV Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 39. Europe HIV Therapeutics Market Size Market Share by Application (2016-2021) Table 40. Middle East & Africa HIV Therapeutics Market Size by Region (2016-2021) & ($ Millions) Table 41. Middle East & Africa HIV Therapeutics Market Size Market Share by Region (2016-2021) Table 42. Middle East & Africa HIV Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 43. Middle East & Africa HIV Therapeutics Market Size Market Share by Type (2016-2021) Table 44. Middle East & Africa HIV Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 45. Middle East & Africa HIV Therapeutics Market Size Market Share by Application (2016-2021) Table 46. Key and Potential Regions of HIV Therapeutics Table 47. Key Application and Potential Industries of HIV Therapeutics Table 48. Key Challenges of HIV Therapeutics Table 49. Key Trends of HIV Therapeutics Table 50. Global HIV Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 51. Global HIV Therapeutics Market Size Market Share Forecast by Regions (2021-2026) Table 52. Global HIV Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions) Table 53. Global HIV Therapeutics Market Size Market Share Forecast by Type (2021-2026) Table 54. Global HIV Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions) Table 55. Global HIV Therapeutics Market Size Market Share Forecast by Application (2021-2026) Table 56. Boehringer Ingelheim International GmbH Details, Company Type, HIV Therapeutics Area Served and Its Competitors Table 57. Boehringer Ingelheim International GmbH HIV Therapeutics Product Offered Table 58. Boehringer Ingelheim International GmbH HIV Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 59. Boehringer Ingelheim International GmbH Main Business Table 60. Boehringer Ingelheim International GmbH Latest Developments Table 61. Merck & Co. Details, Company Type, HIV Therapeutics Area Served and Its Competitors Table 62. Merck & Co. HIV Therapeutics Product Offered Table 63. Merck & Co. Main Business Table 64. Merck & Co. HIV Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 65. Merck & Co. Latest Developments Table 66. ViiV Healthcare Details, Company Type, HIV Therapeutics Area Served and Its Competitors Table 67. ViiV Healthcare HIV Therapeutics Product Offered Table 68. ViiV Healthcare Main Business Table 69. ViiV Healthcare HIV Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 70. ViiV Healthcare Latest Developments Table 71. AbbVie Details, Company Type, HIV Therapeutics Area Served and Its Competitors Table 72. AbbVie HIV Therapeutics Product Offered Table 73. AbbVie Main Business Table 74. AbbVie HIV Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 75. AbbVie Latest Developments Table 76. F. Hoffmann-La Roche Ltd. Details, Company Type, HIV Therapeutics Area Served and Its Competitors Table 77. F. Hoffmann-La Roche Ltd. HIV Therapeutics Product Offered Table 78. F. Hoffmann-La Roche Ltd. Main Business Table 79. F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 80. F. Hoffmann-La Roche Ltd. Latest Developments Table 81. Teva Pharmaceutical Industries Ltd. Details, Company Type, HIV Therapeutics Area Served and Its Competitors Table 82. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Product Offered Table 83. Teva Pharmaceutical Industries Ltd. Main Business Table 84. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 85. Teva Pharmaceutical Industries Ltd. Latest Developments Table 86. Bristol-Myers Squibb Details, Company Type, HIV Therapeutics Area Served and Its Competitors Table 87. Bristol-Myers Squibb HIV Therapeutics Product Offered Table 88. Bristol-Myers Squibb Main Business Table 89. Bristol-Myers Squibb HIV Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 90. Bristol-Myers Squibb Latest Developments Table 91. Gilead Sciences Details, Company Type, HIV Therapeutics Area Served and Its Competitors Table 92. Gilead Sciences HIV Therapeutics Product Offered Table 93. Gilead Sciences Main Business Table 94. Gilead Sciences HIV Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 95. Gilead Sciences Latest Developments Table 96. Johnson & Johnson Details, Company Type, HIV Therapeutics Area Served and Its Competitors Table 97. Johnson & Johnson HIV Therapeutics Product Offered Table 98. Johnson & Johnson Main Business Table 99. Johnson & Johnson HIV Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 100. Johnson & Johnson Latest Developments Table 101. Cipla Limited Details, Company Type, HIV Therapeutics Area Served and Its Competitors Table 102. Cipla Limited HIV Therapeutics Product Offered Table 103. Cipla Limited Main Business Table 104. Cipla Limited HIV Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 105. Cipla Limited Latest Developments List of Figures Figure 1. HIV Therapeutics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global HIV Therapeutics Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global HIV Therapeutics Market Size Market Share by Type in 2020 Figure 7. HIV Therapeutics in Hospitals Figure 8. Global HIV Therapeutics Market: Hospitals (2016-2021) & ($ Millions) Figure 9. HIV Therapeutics in Clinics Figure 10. Global HIV Therapeutics Market: Clinics (2016-2021) & ($ Millions) Figure 11. HIV Therapeutics in Labs Figure 12. Global HIV Therapeutics Market: Labs (2016-2021) & ($ Millions) Figure 13. Global HIV Therapeutics Market Size Market Share by Application in 2020 Figure 14. Global HIV Therapeutics Revenue Market Share by Player in 2020 Figure 15. Global HIV Therapeutics Market Size Market Share by Regions (2016-2021) Figure 16. Americas HIV Therapeutics Market Size 2016-2021 ($ Millions) Figure 17. APAC HIV Therapeutics Market Size 2016-2021 ($ Millions) Figure 18. Europe HIV Therapeutics Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa HIV Therapeutics Market Size 2016-2021 ($ Millions) Figure 20. Americas HIV Therapeutics Market Size Market Share by Country in 2020 Figure 21. Americas HIV Therapeutics Market Size Market Share by Type in 2020 Figure 22. Americas HIV Therapeutics Market Size Market Share by Application in 2020 Figure 23. United States HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC HIV Therapeutics Market Size Market Share by Regions in 2020 Figure 27. APAC HIV Therapeutics Market Size Market Share by Type in 2020 Figure 28. APAC HIV Therapeutics Market Size Market Share by Application in 2020 Figure 29. China HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 33. India HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe HIV Therapeutics Market Size Market Share by Country in 2020 Figure 36. Europe HIV Therapeutics Market Size Market Share by Type in 2020 Figure 37. Europe HIV Therapeutics Market Size Market Share by Application in 2020 Figure 38. Germany HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 39. France HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 40. UK HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa HIV Therapeutics Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa HIV Therapeutics Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa HIV Therapeutics Market Size Market Share by Application in 2020 Figure 46. Egypt HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country HIV Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 52. APAC HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 53. Europe HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 55. United States HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 56. Canada HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 57. Mexico HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 58. Brazil HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 59. China HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 60. Japan HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 61. Korea HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 63. India HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 64. Australia HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 65. Germany HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 66. France HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 67. UK HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 68. Italy HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 69. Russia HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 70. Spain HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 71. Egypt HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 72. South Africa HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 73. Israel HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 74. Turkey HIV Therapeutics Market Size 2021-2026 ($ Millions) Figure 75. GCC Country HIV Therapeutics Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 HIV 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K00128) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 HIV 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |